Authors
Loading...
A two-stage trial design demonstrates efficient dose optimization in oncology, highlighting improved patient safety.
Takeda et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: